Block, Matthew S. http://orcid.org/0000-0001-5692-4219
Dietz, Allan B.
Gustafson, Michael P. http://orcid.org/0000-0002-5514-7072
Kalli, Kimberly R.
Erskine, Courtney L.
Youssef, Bahaaeldin
Vijay, Geraldine V.
Allred, Jacob B.
Pavelko, Kevin D. http://orcid.org/0000-0001-7555-1315
Strausbauch, Michael A.
Lin, Yi
Grudem, Megan E.
Jatoi, Aminah http://orcid.org/0000-0002-1081-189X
Klampe, Carolyn M.
Wahner-Hendrickson, Andrea E.
Weroha, S. John
Glaser, Gretchen E.
Kumar, Amanika
Langstraat, Carrie L.
Solseth, Mary L.
Deeds, Michael C.
Knutson, Keith L. http://orcid.org/0000-0001-9932-4467
Cannon, Martin J.
Article History
Received: 7 April 2020
Accepted: 21 September 2020
First Online: 14 October 2020
Competing interests
: K.L.K. is an inventor on a patent filed by the Mayo Clinic, entitled ‘Immunity to Folate Receptors’, which is currently licensed to Marker Therapeutics, Inc. of Houston, TX. M.J.C. is an inventor on a patent filed by the University of Arkansas, entitled ‘Inhibition of dendritic cell-driven regulatory T cell activation and potentiation of tumor antigen-specific T cell responses by interleukin-15 and MAP kinase inhibitor’. The remaining authors have no competing interests.